These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 21681492)
1. Arterial therapies of colorectal cancer metastases to the liver. de Baere T; Deschamps F Abdom Imaging; 2011 Dec; 36(6):661-70. PubMed ID: 21681492 [TBL] [Abstract][Full Text] [Related]
2. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization). Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635 [TBL] [Abstract][Full Text] [Related]
3. Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded). de Baere T; Tselikas L; Boige V; Ducreux M; Malka D; Goéré D; Benahim E; Deschamps F Bull Cancer; 2017 May; 104(5):402-406. PubMed ID: 27993355 [TBL] [Abstract][Full Text] [Related]
4. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases. Kingham TP; D'Angelica M; Kemeny NE J Surg Oncol; 2010 Dec; 102(8):988-95. PubMed ID: 21166003 [TBL] [Abstract][Full Text] [Related]
5. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. Elias D; Lasser P; Rougier P; Ducreux M; Bognel C; Roche A J Am Coll Surg; 1995 Feb; 180(2):213-9. PubMed ID: 7850058 [TBL] [Abstract][Full Text] [Related]
6. Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review. Xing M; Kooby DA; El-Rayes BF; Kokabi N; Camacho JC; Kim HS J Surg Oncol; 2014 Aug; 110(2):182-96. PubMed ID: 24760444 [TBL] [Abstract][Full Text] [Related]
7. Regional chemotherapy for colorectal cancer metastatic to the liver. Venook AP; Stagg RJ; Lewis BJ Oncology (Williston Park); 1988 Mar; 2(3):19-26. PubMed ID: 3079322 [TBL] [Abstract][Full Text] [Related]
8. Liver-directed therapies: does it make sense in the current therapeutic strategy for patients with confined liver colorectal metastases? Seront E; Van den Eynde M Clin Colorectal Cancer; 2012 Sep; 11(3):177-84. PubMed ID: 22306027 [TBL] [Abstract][Full Text] [Related]
9. Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries. Lauenstein TC; Heusner TA; Hamami M; Ertle J; Schlaak JF; Gerken G; Bockisch A; Antoch G Rofo; 2011 Nov; 183(11):1058-64. PubMed ID: 21959887 [TBL] [Abstract][Full Text] [Related]
12. Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver. Pwint TP; Midgley R; Kerr DJ Semin Oncol; 2010 Apr; 37(2):149-59. PubMed ID: 20494707 [TBL] [Abstract][Full Text] [Related]
13. Interventional oncologic approaches to liver metastases. Mahnken AH; Pereira PL; de Baère T Radiology; 2013 Feb; 266(2):407-30. PubMed ID: 23362094 [TBL] [Abstract][Full Text] [Related]
14. [Chemoperfusion and embolization in the treatment of liver metastases]. Vogl TJ; Mack MG; Eichler K; Zangos S; Naguib NN; Gruber-Rouh T Rofo; 2011 Jan; 183(1):12-23. PubMed ID: 21113865 [TBL] [Abstract][Full Text] [Related]
15. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates. Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M; In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751 [TBL] [Abstract][Full Text] [Related]
16. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920 [TBL] [Abstract][Full Text] [Related]
17. Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy. Kouri BE Tech Vasc Interv Radiol; 2018 Dec; 21(4):205-222. PubMed ID: 30545499 [TBL] [Abstract][Full Text] [Related]
18. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019 [TBL] [Abstract][Full Text] [Related]
19. Surgical treatment and other regional treatments for colorectal cancer liver metastases. Yoon SS; Tanabe KK Oncologist; 1999; 4(3):197-208. PubMed ID: 10394588 [TBL] [Abstract][Full Text] [Related]
20. The state of regional therapy in the management of metastatic colorectal cancer to the liver. Cho M; Gong J; Fakih M Expert Rev Anticancer Ther; 2016; 16(2):229-45. PubMed ID: 26652741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]